Pelubiprofen-13C,d3

CAT:

804-HY-12383S-01

Size:

5 mg

Price:

Ask

For price, please contact [email protected]

UNSPSC Description: Pelubiprofen-13C,d3 is the 13C- and deuterium labeled Pelubiprofen. Pelubiprofen, an orally active and non-steroidal anti-inflammatory drug, is a member of the 2-arylpropionic acid family and has relatively selective effects on COX-2 activity. Pelubiprofen inhibits COX activity and the transforming growth factor-β activated kinase 1-IκB kinase β-NF-κB pathway, and has significant anti-inflammatory and analgesic effects[1].
Target Antigen: COX; Isotope-Labeled Compounds
Type: Isotope-Labeled Compounds
Related Pathways: Immunology/Inflammation;Others
Field of Research: Inflammation/Immunology; Neurological Disease
Solubility: 10 mM in DMSO
Smiles: OC(C([13C]([2H])([2H])[2H])C(C=C1)=CC=C1/C=C2C(CCCC/2)=O)=O
Molecular Weight: 262.32
References & Citations: [1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-223.|[2]Choi IA, Baek HJ, et al. Comparison of the efficacy and safety profiles of a pelubiprofen versus celecoxib in patients with rheumatoid arthritis: a 6-week, multicenter, randomized, double-blind, phase III, non-inferiority clinical trial. BMC Musculoskelet Disord. 2014 Nov 18;15:375.
Shipping Conditions: Room temperature
Clinical Information: No Development Reported